Mesoblast Ltd
MESO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001345099
No open-market purchases or sales by Mesoblast Ltd insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $53.3M in total; no superinvestor holds it.
Other share classesMEOBF
Q2 2024 vs. Q1 2024
How the institutions holding Mesoblast Ltd changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 26 | 1 | 39 | +14 |
| Shares | 1.08M | 500 | 1.48M | +400.3K (+36.9%) |
| Value | $5.48M | $2.00K | $10.1M | +$4.63M (+84.4%) |
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Mesoblast Ltd at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 82,576 | $562.3K | 0.00% |
| Citadel Advisors LLC | 77,294 | $526.4K | 0.00% |
| Jane Street Group, LLC | 58,143 | $396.0K | 0.00% |
| Rockbridge Investment Management, LCC | 49,150 | $334.7K | 0.05% |
| Cantor Fitzgerald, L. P. | 16,195 | $110.3K | 0.02% |
| XTX Topco Ltd | 15,063 | $102.6K | 0.01% |
| Rathbone Brothers plc | 14,017 | $95.5K | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 12,500 | $85.0K | 0.00% |
| Pine Valley Investments Ltd Liability Co | 11,714 | $79.8K | 0.01% |
| Perkins Coie Trust Co | 10,000 | $68.1K | 0.02% |
| Simplex Trading, LLC | 8,652 | $58.0K | 0.00% |
| Advisors Preferred, LLC | 6,781 | $46.0K | 0.01% |
| Quadrant Capital Group LLC | 5,893 | $40.1K | 0.00% |
| Signaturefd, LLC | 2,407 | $16.4K | 0.00% |
| Lindbrook Capital, LLC | 1,526 | $10.4K | 0.00% |
| Parallel Advisors, LLC | 756 | $5.15K | 0.00% |
| Ronald Blue Trust, Inc. | 45 | $225 | 0.00% |
Sold out (3)
Institutions that held Mesoblast Ltd at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| VGI Partners Ltd | 117,243 | $587.4K |
| HRT Financial LP | 57,815 | $289.0K |
| Tower Research Capital LLC (TRC) | 3,410 | $17.1K |
Not filed for Q2 2024 yet (1)
Institutions that held Mesoblast Ltd at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Cutler Group LP | 500 | $2.00K |